Center for Drug Evaluation and Research

Results: 4314



#Item
991U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
992U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
993U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
994Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Anesthetic and Analgesic Drug Products Advisory Committee Meeting June 11-12, 2014 Location: The FDA White Oak Campus, Building

Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Anesthetic and Analgesic Drug Products Advisory Committee Meeting June 11-12, 2014 Location: The FDA White Oak Campus, Building

Add to Reading List

Source URL: www.fda.gov

Language: English
995August 14, 2014, Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) - Webcast Information The Center for Drug Evaluation and Research (CDER) provided a live webcast of the August 14, 2014, meeting of the P

August 14, 2014, Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) - Webcast Information The Center for Drug Evaluation and Research (CDER) provided a live webcast of the August 14, 2014, meeting of the P

Add to Reading List

Source URL: www.fda.gov

    996Microsoft PowerPoint - Final OTC Drug Regulation lecture[removed]pptx

    Microsoft PowerPoint - Final OTC Drug Regulation lecture[removed]pptx

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    997Pharmacology / Healthcare Distribution Management Association / Health Industry Business Communications Council / Medical ethics / Food and Drug Administration / Pharmaceutical industry / Patient safety / Medicine / Pharmaceutical sciences / Health

    July 11, 2002 Mary C. Gross Office of Drug Safety Center for Drug Evaluation and Research

    Add to Reading List

    Source URL: www.fda.gov

    Language: English - Date: 2002-11-16 13:02:41
    998Microsoft Word - CRI November 2010 Newsletter v.2.docx

    Microsoft Word - CRI November 2010 Newsletter v.2.docx

    Add to Reading List

    Source URL: aaci-cancer.org

    Language: English - Date: 2011-02-11 12:13:10
    999Fundamental Elements in Gene Vector Development The information provided below is intended to aid investigators in understanding common elements in the development of gene therapy vectors from preclinical testing to clin

    Fundamental Elements in Gene Vector Development The information provided below is intended to aid investigators in understanding common elements in the development of gene therapy vectors from preclinical testing to clin

    Add to Reading List

    Source URL: gtrp.org

    Language: English - Date: 2014-03-13 11:56:15
    1000IND-Enabling Studies: Preclinical Perspective Mercedes A. Serabian, M.S., DABT FDA/CBER/OCTGT/DCEPT/PTB 11th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases

    IND-Enabling Studies: Preclinical Perspective Mercedes A. Serabian, M.S., DABT FDA/CBER/OCTGT/DCEPT/PTB 11th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases

    Add to Reading List

    Source URL: www.gts.ucdavis.edu

    Language: English - Date: 2012-12-03 16:57:55